SPC417
Lasmidítan eða lyfjafræðilega viðunandi salt þar af
:
Veitt:
6.1.2023:
15.2.2023:
15.9.2024
:
1.4.2035:
Rayvow
6.1.2023
15.2.2023
15.9.2024
1.4.2035
:
EU/1/21/1587:
31.8.2022
:
EU/1/21/1587:
17.8.2022
:
Colucid Pharmaceuticals, Inc.:
Lilly Corporate Center, Indianapolis US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113 Reykjavík